QIAGEN Launches Rapid GI Infection Test in the US, Approved by FDA
QIAGEN (NYSE:QGEN, Frankfurt Prime Standard: QIA)))) today announced the launch of the QIAstat-Dx Gastrointestinal Panel 2 in the United States. The launch comes after the recent clearance of the syndromic test for